Search
TScan Therapeutics Inc
TCRXAdd to Watchlist
0.920USD
+0.020+2.23%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
55.29MMarket Cap
LossP/E TTM
TScan Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of TScan Therapeutics Inc is 8.78, ranking 84 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.96, which is -43.32% below the recent high of -0.54 and -1226.02% above the recent low of -12.74.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
